%20_%20Alberto%20Mart%C3%ADnez%20y%20Mar%C3%ADa%20de%20Oyarz%C3%A1bal%20(Siemens)_edited.jpg?width=2000&height=1333&name=%C3%93scar%20Elices%20y%20Pedro%20Luis%20Cobiella%20(Hospiten)%20_%20Alberto%20Mart%C3%ADnez%20y%20Mar%C3%ADa%20de%20Oyarz%C3%A1bal%20(Siemens)_edited.jpg)
Siemens Healthineers will be Hospiten's trusted technological partner in its growth strategy with the development of the new hospital in Boadilla (Madrid), a center that integrates a complete portfolio of state-of-the-art equipment for continuous care in the area of diagnostic imaging and advanced therapies, providing solutions that set a new standard in precision, efficiency and quality of care.
Hospiten Madrid Boadilla will incorporate advanced equipment such as a 3T Magnetic Resonance Imaging (MRI) and Photon Counting Computed Tomography (TCPC), a milestone in the field of diagnostic imaging that redefines the capacity for visualization and detail with optimized dose. This commitment positions the new center as a benchmark in diagnostic imaging and advanced therapies and consolidates a strategic collaboration aimed at long-term care transformation.
The strategic agreement between Siemens Healthineers and Hospiten, for a period of ten years, will enable the incorporation of more than 25 high-tech devices, together with an integral solution for advanced clinical post-processing, with an investment of 22 million euros. In addition, the agreement includes evolutionary maintenance and training and research programs.
This alliance is part of Hospiten's modernization process, where innovation, clinical research and the adoption of disruptive technology are the essential pillars of its evolution as a global brand and as a hospital network with a teaching and international vocation, focused on people. This is reflected in its strategic and communication plan, which stresses the importance of reinforcing its positioning based on innovation, advanced technology and excellent healthcare experience.
Although technological renovation at Hospiten is part of the group's ongoing commitment to improving healthcare - including the recent incorporation of advanced equipment such as the MR Altea at the Hospiten Sur University Hospital (Tenerife) - the current strategic priority is focused on the creation of an integral technological ecosystem at the Hospiten Madrid Boadilla Hospital, conceived from the outset to operate with the highest standards of diagnostic precision and operational efficiency.
This project contributes directly to Hospiten's guiding purpose: "Building an ecosystem of wellbeing around people", a vision that understands healthcare as a space of connection between technology, community and continuous care. It also faithfully reflects its mission: "We are a hospital network with more than 55 years dedicated to understanding people. Your well-being is our priority, and we care for and value it over time. We have 20 hospitals in 5 countries".
"Hospiten Madrid Boadilla is a clear expression of our vision of the future, committed to the most advanced technology as a lever to offer more precise, efficient and, above all, more humane medicine, always at the service of people's well-being," says Pedro Luis Cobiella, vice-president and CEO of Hospiten.
For Alberto Martínez, CEO of Siemens Healthineers, "this collaboration incorporates state-of-the-art solutions in diagnostic imaging and advanced therapies that contribute positively to the precision, efficiency and quality of care for Hospiten patients. It also reinforces our purpose and the impact that we believe is only possible to achieve through partnerships like this one."
The collaboration between Hospiten and Siemens Healthineers consolidates a shared model based on technological excellence, process efficiency and a constant focus on more humane, safe and personalized care. With the new Hospiten Madrid Boadilla Hospital, both organizations reaffirm their commitment to building the future of diagnostic imaging and advanced therapies in Spain.
About Siemens Healthineers
At Siemens Healthineers we are pioneers in healthcare. For everyone. Everywhere. In a sustainable way. As a leader in healthcare technology, we want to advance a world where innovations in healthcare create new possibilities with minimal impact on our planet. By constantly bringing innovations to market, we enable healthcare professionals to innovate personalized care, achieve operational excellence and transform the healthcare system.
Our portfolio, ranging from in vitro and in vivo diagnostics to image-guided therapy and cancer treatment, is crucial to clinical and treatment decision-making. With the unique combination of our strengths in digital twin1, precision therapy, as well as digital, data and artificial intelligence (AI), we are well positioned to tackle the biggest challenges in healthcare. We will continue to leverage these strengths to help overcome the world's most threatening diseases, enable efficient operations and expand access to healthcare.
We are a team of 73,000 Healthineers in more than 70 countries who passionately push the boundaries of what is possible in healthcare to help improve the lives of people around the world.
More information at: www.siemens-healthineers.com
About Hospiten
Hospiten is an international healthcare network with more than 55 years of experience committed to providing the highest quality service, with 20 private medical-hospital centers in Spain, the Dominican Republic, Mexico, Jamaica and Panama, in addition to 175 outpatient medical centers, under the Clinic Assist brand. Founded by Dr. Pedro Luis Cobiella, it attends more than three million patients a year from all over the world and has a staff of more than 5,000 people, care that will be reinforced in the Madrid region thanks to the construction of a general university hospital in Boadilla del Monte, which is due to be completed in 2026.
MD Anderson Cancer Center Madrid - Hospiten is a subsidiary of the prestigious MD Anderson Cancer Center in Houston (Texas, USA). With more than 20 years of history in Spain, MD Anderson Madrid - Hospiten currently has a Phase I Clinical Trials Unit, more than 150 medical specialists trained in oncology, a total of 87 hospital beds and state-of-the-art technological equipment for the diagnosis and treatment of different types of cancer.
This article is an English translation generated with AI from the original Spanish content. While we review content for clarity, the information is provided for general informational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional for diagnosis or treatment.